Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare’s DoseMeRx Integration Wolters Kluwer Targets Precision Dosing with Tabula Rasa HealthCare’s DoseMeRx Integration Wolters Kluwer, Health, a global provider of trusted clinical technology and evidence-based solutions, has announced the integration of DoseMeRx„¢, a Tabula Rasa Healthcare precision dosing solution, with Sentri7s Antimicrobial Stewardship (AMS) solution. With a single click, pharmacists can review patient-specific parenteral vancomycin dose recommendations calculated automatically using key clinical data such as patient weight, laboratory values, creatinine levels and drug administration times. Dosing and monitoring of vancomycin can be complex, requiring patient data and laboratory results to individualize the dose for each patient, said Charles Cornish, Executive Vice President, Hospitals Business Unit, TRHC. By integrating our precision dosing platform with Wolters Kluwers Sentri7 solution, pharmacists across the country will have convenient, integrated real-time Bayesian dosing support to align with the best practices in the American Society of Health System Pharmacists 2020 guideline recommendation for dosing and monitoring of vancomycin.